Prenatal Diagnostics Market Forecast (2024-2031)
The Prenatal Diagnostics Market is expected to register a CAGR of 8.3% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented By Procedure (Ultrasonography, Chorionic Villus Sampling, Amniocentesis, Percutaneous Umbilical Blood Sampling, Preimplantation Genetic Diagnosis); Product and Services (Instruments, Consumables, Services); Application ( Chromosome Abnormality, Genetic Disorders); End User (Hospitals, Diagnostic Laboratories). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Prenatal Diagnostics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Prenatal Diagnostics Market Segmentation
Procedure- Ultrasonography
- Chorionic Villus Sampling
- Amniocentesis
- Percutaneous Umbilical Blood Sampling
- Preimplantation Genetic Diagnosis
- Instruments
- Consumables
- Services
- Chromosome Abnormality
- Genetic Disorders
- Hospitals
- Diagnostic Laboratories
- Hospitals
- Diagnostic Laboratories
Strategic Insights
Prenatal Diagnostics Market Growth Drivers- Technological Innovation: New technologies, such as non-invasive prenatal testing, or NIPT, and other advanced imaging technologies, are dramatically changing the playing field. Those technologies used here seek to provide safer and more accurate diagnostics on the health of the fetus, thereby enabling risks from invasive procedures to be avoided altogether. Advanced diagnostic capabilities, including the ability to provide timely interventions, promote an increasing demand for more advanced prenatal testing solutions on the part of expectant parents.
- Advanced Maternal Age: Society has evolved, and most women prefer delivering their babies at an older age, which indeed puts them at a higher risk of genetic disorders and other complications during pregnancy. Therefore, this factor calls for additional comprehensive prenatal screenings and diagnostics because older women seek to take control and ensure sound pregnancies. Actually, it is the major risks that compel the couple to invest in these new prenatal care services.
- Increased Awareness and Education: An increased awareness about the importance of prenatal diagnostics is changing consumer behavior. As a result, the increase in educational activity and knowledge accessibility empowers expectant parents to seek informed choices in health for both the mother and the baby. This change towards proactive health services is driving the phenomenon for prenatal testing services where parents seek early detection and prevention of possible issues.
- Trend toward Non-Invasive Testing: There is a trend toward non-invasive prenatal testing that is well-known to provide safe and accurate evaluations of fetal condition without the risks of the invasive procedures themselves. Such a trend has really picked up steam over the years with advances in technology as well as awareness among expected parents, thereby increasing the demand for NIPT and making it an appropriate initial approach for most prenatal tests.
- Integration of Digital Health Solutions: With the integration of telemedicine and mobile health applications, it is opening a doorway into introducing new digital health technologies in prenatal diagnostics. Results of prenatal testing and remote consultations will enable improvements to enhance patient convenience and engagement. It is part of an emerging trend of demand for personalized and accessible health solutions in prenatal diagnostics among expectant parents.
- Focus on Genetic Screening: There is an expanding trend of genetic screening in the prenatal diagnostics market. In this context, with advancing knowledge and the increasing recognition of hereditary conditions, expectant parents seek the most extensive assessments of genetics to ascertain the risks at any early stage. This trend will eventually drive the creation of more targeted testing solutions, collaboration between healthcare providers and genetic counselors, and, as a consequence, better delivery of care.
- Expansion into Emerging Markets: The growth markets represent a large opportunity for the prenatal diagnostics sector. With developing healthcare infrastructure and increasing awareness about prenatal care, this increases demand for higher diagnostic technologies. Low-cost testing platforms and education into hitherto resource-scarce areas may hence be capitalized on to achieve greater access to prenatal services.
- Development of Advanced Biomarkers: New Biomarkers Discovery and Identification Biomarkers for prenatal diagnostics are an area that is going to witness innovative 'breakthroughs'. Gains in the cutting edge both in genomics and proteomics will be able to open routes leading to the development of very sensitive and predictive tests on a wide range of conditions. Here is how this possible route towards precision medicine enhances the assessment of fetal health while bringing along a way of personalising prenatal care for wellness-conscious parents.
- Collaborations with Tech Companies: Companies dealing with technologies will collaborate with others to hasten innovation in prenatal diagnostics. There is an integration of artificial intelligence and machine learning in diagnostic software, accelerating data analysis and risk evaluation. This might increase product offerings, facilitate more intuitive, user-friendly platforms, and change the face of prenatal care for expectant parents.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Prenatal Diagnostics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Prenatal Diagnostics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to grow at a CAGR of 8.3%
advanced maternal age and increased awareness and education about prenatal diagnostics are the major factors boosting the prenatal diagnostics market growth
The North America region accounts for highest revenue share prenatal diagnostics market
GE Healthcare (General Electric Company), Thermo Fisher Scientific, Inc., Illumina, Inc., F. Hoffman-La Roche Ltd., Beijing Genomics Institute, Agilent Technologies, Inc., Perkinelmer, Inc., Hologic, Inc., Natera, Inc., Quest Diagnostics, Inc. are the some of the key market players operating in the prenatal diagnostics market
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prenatal Diagnostics Market - By Procedure
1.3.2 Prenatal Diagnostics Market - By Product and Services
1.3.3 Prenatal Diagnostics Market - By Application
1.3.4 Prenatal Diagnostics Market - By End User
1.3.5 Prenatal Diagnostics Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PRENATAL DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PRENATAL DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PRENATAL DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PRENATAL DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. PRENATAL DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PRENATAL DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - PROCEDURE
7.1. OVERVIEW
7.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
7.3. ULTRASONOGRAPHY
7.3.1. Overview
7.3.2. Ultrasonography Market Forecast and Analysis
7.4. CHORIONIC VILLUS SAMPLING
7.4.1. Overview
7.4.2. Chorionic Villus Sampling Market Forecast and Analysis
7.5. AMNIOCENTESIS
7.5.1. Overview
7.5.2. Amniocentesis Market Forecast and Analysis
7.6. PERCUTANEOUS UMBILICAL BLOOD SAMPLING
7.6.1. Overview
7.6.2. Percutaneous Umbilical Blood Sampling Market Forecast and Analysis
7.7. PREIMPLANTATION GENETIC DIAGNOSIS
7.7.1. Overview
7.7.2. Preimplantation Genetic Diagnosis Market Forecast and Analysis
8. PRENATAL DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT AND SERVICES
8.1. OVERVIEW
8.2. PRODUCT AND SERVICES MARKET FORECASTS AND ANALYSIS
8.3. INSTRUMENTS
8.3.1. Overview
8.3.2. Instruments Market Forecast and Analysis
8.3.3. Ultrasound Devices Market
8.3.3.1. Overview
8.3.3.2. Ultrasound Devices Market Forecast and Analysis
8.3.4. Next-Generation Sequencing Systems Market
8.3.4.1. Overview
8.3.4.2. Next-Generation Sequencing Systems Market Forecast and Analysis
8.3.5. Polymerase Chain Reaction Instruments Market
8.3.5.1. Overview
8.3.5.2. Polymerase Chain Reaction Instruments Market Forecast and Analysis
8.3.6. Microarrays Market
8.3.6.1. Overview
8.3.6.2. Microarrays Market Forecast and Analysis
8.3.7. Others Market
8.3.7.1. Overview
8.3.7.2. Others Market Forecast and Analysis
8.4. CONSUMABLES
8.4.1. Overview
8.4.2. Consumables Market Forecast and Analysis
8.5. SERVICES
8.5.1. Overview
8.5.2. Services Market Forecast and Analysis
9. PRENATAL DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CHROMOSOME ABNORMALITY
9.3.1. Overview
9.3.2. Chromosome Abnormality Market Forecast and Analysis
9.4. GENETIC DISORDERS
9.4.1. Overview
9.4.2. Genetic Disorders Market Forecast and Analysis
10. PRENATAL DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. DIAGNOSTIC LABORATORIES
10.4.1. Overview
10.4.2. Diagnostic Laboratories Market Forecast and Analysis
11. PRENATAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Prenatal Diagnostics Market Overview
11.1.2 North America Prenatal Diagnostics Market Forecasts and Analysis
11.1.3 North America Prenatal Diagnostics Market Forecasts and Analysis - By Procedure
11.1.4 North America Prenatal Diagnostics Market Forecasts and Analysis - By Product and Services
11.1.5 North America Prenatal Diagnostics Market Forecasts and Analysis - By Application
11.1.6 North America Prenatal Diagnostics Market Forecasts and Analysis - By End User
11.1.7 North America Prenatal Diagnostics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Prenatal Diagnostics Market
11.1.7.1.1 United States Prenatal Diagnostics Market by Procedure
11.1.7.1.2 United States Prenatal Diagnostics Market by Product and Services
11.1.7.1.3 United States Prenatal Diagnostics Market by Application
11.1.7.1.4 United States Prenatal Diagnostics Market by End User
11.1.7.2 Canada Prenatal Diagnostics Market
11.1.7.2.1 Canada Prenatal Diagnostics Market by Procedure
11.1.7.2.2 Canada Prenatal Diagnostics Market by Product and Services
11.1.7.2.3 Canada Prenatal Diagnostics Market by Application
11.1.7.2.4 Canada Prenatal Diagnostics Market by End User
11.1.7.3 Mexico Prenatal Diagnostics Market
11.1.7.3.1 Mexico Prenatal Diagnostics Market by Procedure
11.1.7.3.2 Mexico Prenatal Diagnostics Market by Product and Services
11.1.7.3.3 Mexico Prenatal Diagnostics Market by Application
11.1.7.3.4 Mexico Prenatal Diagnostics Market by End User
11.2. EUROPE
11.2.1 Europe Prenatal Diagnostics Market Overview
11.2.2 Europe Prenatal Diagnostics Market Forecasts and Analysis
11.2.3 Europe Prenatal Diagnostics Market Forecasts and Analysis - By Procedure
11.2.4 Europe Prenatal Diagnostics Market Forecasts and Analysis - By Product and Services
11.2.5 Europe Prenatal Diagnostics Market Forecasts and Analysis - By Application
11.2.6 Europe Prenatal Diagnostics Market Forecasts and Analysis - By End User
11.2.7 Europe Prenatal Diagnostics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Prenatal Diagnostics Market
11.2.7.1.1 Germany Prenatal Diagnostics Market by Procedure
11.2.7.1.2 Germany Prenatal Diagnostics Market by Product and Services
11.2.7.1.3 Germany Prenatal Diagnostics Market by Application
11.2.7.1.4 Germany Prenatal Diagnostics Market by End User
11.2.7.2 France Prenatal Diagnostics Market
11.2.7.2.1 France Prenatal Diagnostics Market by Procedure
11.2.7.2.2 France Prenatal Diagnostics Market by Product and Services
11.2.7.2.3 France Prenatal Diagnostics Market by Application
11.2.7.2.4 France Prenatal Diagnostics Market by End User
11.2.7.3 Italy Prenatal Diagnostics Market
11.2.7.3.1 Italy Prenatal Diagnostics Market by Procedure
11.2.7.3.2 Italy Prenatal Diagnostics Market by Product and Services
11.2.7.3.3 Italy Prenatal Diagnostics Market by Application
11.2.7.3.4 Italy Prenatal Diagnostics Market by End User
11.2.7.4 Spain Prenatal Diagnostics Market
11.2.7.4.1 Spain Prenatal Diagnostics Market by Procedure
11.2.7.4.2 Spain Prenatal Diagnostics Market by Product and Services
11.2.7.4.3 Spain Prenatal Diagnostics Market by Application
11.2.7.4.4 Spain Prenatal Diagnostics Market by End User
11.2.7.5 United Kingdom Prenatal Diagnostics Market
11.2.7.5.1 United Kingdom Prenatal Diagnostics Market by Procedure
11.2.7.5.2 United Kingdom Prenatal Diagnostics Market by Product and Services
11.2.7.5.3 United Kingdom Prenatal Diagnostics Market by Application
11.2.7.5.4 United Kingdom Prenatal Diagnostics Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Prenatal Diagnostics Market Overview
11.3.2 Asia-Pacific Prenatal Diagnostics Market Forecasts and Analysis
11.3.3 Asia-Pacific Prenatal Diagnostics Market Forecasts and Analysis - By Procedure
11.3.4 Asia-Pacific Prenatal Diagnostics Market Forecasts and Analysis - By Product and Services
11.3.5 Asia-Pacific Prenatal Diagnostics Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Prenatal Diagnostics Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Prenatal Diagnostics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Prenatal Diagnostics Market
11.3.7.1.1 Australia Prenatal Diagnostics Market by Procedure
11.3.7.1.2 Australia Prenatal Diagnostics Market by Product and Services
11.3.7.1.3 Australia Prenatal Diagnostics Market by Application
11.3.7.1.4 Australia Prenatal Diagnostics Market by End User
11.3.7.2 China Prenatal Diagnostics Market
11.3.7.2.1 China Prenatal Diagnostics Market by Procedure
11.3.7.2.2 China Prenatal Diagnostics Market by Product and Services
11.3.7.2.3 China Prenatal Diagnostics Market by Application
11.3.7.2.4 China Prenatal Diagnostics Market by End User
11.3.7.3 India Prenatal Diagnostics Market
11.3.7.3.1 India Prenatal Diagnostics Market by Procedure
11.3.7.3.2 India Prenatal Diagnostics Market by Product and Services
11.3.7.3.3 India Prenatal Diagnostics Market by Application
11.3.7.3.4 India Prenatal Diagnostics Market by End User
11.3.7.4 Japan Prenatal Diagnostics Market
11.3.7.4.1 Japan Prenatal Diagnostics Market by Procedure
11.3.7.4.2 Japan Prenatal Diagnostics Market by Product and Services
11.3.7.4.3 Japan Prenatal Diagnostics Market by Application
11.3.7.4.4 Japan Prenatal Diagnostics Market by End User
11.3.7.5 South Korea Prenatal Diagnostics Market
11.3.7.5.1 South Korea Prenatal Diagnostics Market by Procedure
11.3.7.5.2 South Korea Prenatal Diagnostics Market by Product and Services
11.3.7.5.3 South Korea Prenatal Diagnostics Market by Application
11.3.7.5.4 South Korea Prenatal Diagnostics Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Prenatal Diagnostics Market Overview
11.4.2 Middle East and Africa Prenatal Diagnostics Market Forecasts and Analysis
11.4.3 Middle East and Africa Prenatal Diagnostics Market Forecasts and Analysis - By Procedure
11.4.4 Middle East and Africa Prenatal Diagnostics Market Forecasts and Analysis - By Product and Services
11.4.5 Middle East and Africa Prenatal Diagnostics Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Prenatal Diagnostics Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Prenatal Diagnostics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Prenatal Diagnostics Market
11.4.7.1.1 South Africa Prenatal Diagnostics Market by Procedure
11.4.7.1.2 South Africa Prenatal Diagnostics Market by Product and Services
11.4.7.1.3 South Africa Prenatal Diagnostics Market by Application
11.4.7.1.4 South Africa Prenatal Diagnostics Market by End User
11.4.7.2 Saudi Arabia Prenatal Diagnostics Market
11.4.7.2.1 Saudi Arabia Prenatal Diagnostics Market by Procedure
11.4.7.2.2 Saudi Arabia Prenatal Diagnostics Market by Product and Services
11.4.7.2.3 Saudi Arabia Prenatal Diagnostics Market by Application
11.4.7.2.4 Saudi Arabia Prenatal Diagnostics Market by End User
11.4.7.3 U.A.E Prenatal Diagnostics Market
11.4.7.3.1 U.A.E Prenatal Diagnostics Market by Procedure
11.4.7.3.2 U.A.E Prenatal Diagnostics Market by Product and Services
11.4.7.3.3 U.A.E Prenatal Diagnostics Market by Application
11.4.7.3.4 U.A.E Prenatal Diagnostics Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Prenatal Diagnostics Market Overview
11.5.2 South and Central America Prenatal Diagnostics Market Forecasts and Analysis
11.5.3 South and Central America Prenatal Diagnostics Market Forecasts and Analysis - By Procedure
11.5.4 South and Central America Prenatal Diagnostics Market Forecasts and Analysis - By Product and Services
11.5.5 South and Central America Prenatal Diagnostics Market Forecasts and Analysis - By Application
11.5.6 South and Central America Prenatal Diagnostics Market Forecasts and Analysis - By End User
11.5.7 South and Central America Prenatal Diagnostics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Prenatal Diagnostics Market
11.5.7.1.1 Brazil Prenatal Diagnostics Market by Procedure
11.5.7.1.2 Brazil Prenatal Diagnostics Market by Product and Services
11.5.7.1.3 Brazil Prenatal Diagnostics Market by Application
11.5.7.1.4 Brazil Prenatal Diagnostics Market by End User
11.5.7.2 Argentina Prenatal Diagnostics Market
11.5.7.2.1 Argentina Prenatal Diagnostics Market by Procedure
11.5.7.2.2 Argentina Prenatal Diagnostics Market by Product and Services
11.5.7.2.3 Argentina Prenatal Diagnostics Market by Application
11.5.7.2.4 Argentina Prenatal Diagnostics Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PRENATAL DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1. GE HEALTHCARE
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. THERMO FISHER SCIENTIFIC, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ILLUMINA, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. F. HOFFMAN-LA ROCHE LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BEIJING GENOMICS INSTITUTE
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. AGILENT TECHNOLOGIES, INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PERKINELMER, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. HOLOGIC, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. NATERA, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. QUEST DIAGNOSTICS, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. GE Healthcare (General Electric Company)2. Thermo Fisher Scientific, Inc.3. Illumina, Inc.4. F. Hoffman-La Roche Ltd.5. Beijing Genomics Institute6. Agilent Technologies, Inc.7. Perkinelmer, Inc.8. Hologic, Inc.9. Natera, Inc.10. Quest Diagnostics, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For